Multicenter Trial For Patients With Acute Crohn's Disease

Completed · Phase 2

Conditions studied: Crohn's Disease

In brief

The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.

Key facts

Study ID

NCT00035503

Run by

Teva Branded Pharmaceutical Products R&D, Inc.

Starts

2002-01-31

Expected to finish

2004-01-31

Last updated by the study team

2021-12-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Stuart Weisman — Palo Alto, California, United States
• University of Colorado Medical Center — Denver, Colorado, United States
• Washington Hospital Center — Washington D.C., District of Columbia, United States
• Mark Lamet — Hollywood, Florida, United States
• Wayne Schonfeld — Hollywood, Florida, United States
• Mount Sinai Medical Center — Miami Beach, Florida, United States
• University of Chicago Hospital Medical Center — Chicago, Illinois, United States
• Gerald Dryden — Louisville, Kentucky, United States
• Richard MacDermott — Albany, New York, United States
• Hillary Steinhart — Toronto, Ontario, Canada
• Gary Wild — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.